Clinical Trial Update: Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial investigating cyproheptadine for growth and behavior in pediatric feeding disorders; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Feeding Behaviors
• Feeding Disorders

Drugs mentioned

• Cyproheptadine (cyproheptadine)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Feeding Behaviors | Phase 4 | Status: TERMINATED | Results posted: 2020-01-31